Gufic Group Executive and Leadership Team

Devkinandan Roonghta, the Chief Financial Officer at Gufic Group, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures robust investment in research and development for lyophilized injections. This leadership role involves managing complex budgetary requirements across diverse pharmaceutical product lines. By optimizing cost structures and revenue streams, Devkinandan Roonghta directly impacts the long-term stability of the company. Roonghta maintains rigorous oversight of financial reporting standards, ensuring transparency for stakeholders and investors. Through disciplined fiscal management, the Chief Financial Officer supports the expansion of manufacturing capabilities and the broader market reach of the firm. Ultimately, Roonghta secures the necessary resources to sustain the competitive advantage of the organization within the Indian pharmaceutical landscape, driving consistent growth and operational excellence across all business units.

Nagesh Yarrabathina, the Chief Operating Officer at Gufic Group, manages the end-to-end manufacturing processes for antibiotics, antifungals, and antiviral treatments. Overseeing the production facilities, the Chief Operating Officer ensures strict adherence to quality standards for lyophilized injections. This leadership role involves coordinating supply chain logistics to facilitate consistent delivery to major hospital chains throughout India. By streamlining production workflows, Nagesh Yarrabathina directly impacts the efficiency and output capacity of the company. Yarrabathina monitors operational metrics to identify opportunities for technological upgrades and process improvements. Through the implementation of advanced manufacturing protocols, the Chief Operating Officer maintains the high quality of pharmaceutical products. Ultimately, Yarrabathina drives the operational scale required to meet the increasing demand for specialized medical treatments, ensuring that the manufacturing infrastructure remains aligned with the strategic goals of the organization.

Rajesh Kaul, the Senior President at Gufic Group, drives the overarching corporate strategy and long-term vision for the organization. Overseeing the integration of various business units, the Senior President ensures that research and development efforts translate into market-ready pharmaceutical products. This leadership role involves coordinating with the Board to define the trajectory of the company within the competitive landscape. By aligning departmental objectives with the core mission of the firm, Rajesh Kaul directly impacts the growth and market positioning of the business. Kaul monitors industry trends to identify new opportunities for product diversification and international expansion. Through the synthesis of operational and financial data, the Senior President maintains the focus of the organization on delivering high-quality medical solutions. Ultimately, Kaul secures the strategic direction of the company, ensuring that all divisions contribute effectively to the sustained success of the enterprise.

Shekhar Aley, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare at Gufic Group, directs the commercial strategy for the critical care, nephrology, and neurocare business units. Overseeing the sales force, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare ensures that life-saving injections reach major hospital chains across India. This leadership role involves developing targeted marketing campaigns to communicate the value of advanced pharmaceutical products to medical professionals. By expanding the reach of the critical care portfolio, Shekhar Aley directly impacts the revenue growth and market penetration of the company. Aley manages relationships with key medical facilities to ensure consistent product availability and clinical support. Through the analysis of regional market data, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare optimizes the distribution network to meet the needs of diverse patient populations. Ultimately, Aley secures the commercial success of the organization by driving the adoption of innovative treatments.

Sunil Desai, the Chief Human Resources Officer at Gufic Group, architects the talent acquisition and organizational development strategies. Overseeing the workforce, the Chief Human Resources Officer ensures alignment between human capital and the research-driven mission of the company. This leadership role involves fostering a culture of innovation and technical excellence among scientific and manufacturing teams. By implementing comprehensive training programs, Sunil Desai directly impacts the retention of specialized expertise required for pharmaceutical production. Desai manages performance evaluation systems to drive productivity and professional growth across all departments. Through the cultivation of a high-performance environment, the Chief Human Resources Officer supports the expansion of the international footprint of the firm. Ultimately, Desai secures the human capital necessary to maintain the reputation of the organization as a leader in the pharmaceutical industry, ensuring that the workforce remains capable of executing complex strategic initiatives.